Skip to content
Research Article Open access CC BY 4.0

Revolutionizing Arthritis Treatment: The Synergy of iPSCs and Extracellular Vesicles-based Acellular Therapies for Joint Tissue Repair

Owen R. Thornton, Wenjun Li

Asian Journal of Orthopaedic Research · pp. 330–335 · Published 30 Dec 2022

Abstract

This review discusses the current state of arthritis treatment and the limitations associated with traditional approaches. The review then explores the potential of induced pluripotent stem cells (iPSCs) and extracellular vesicles (EVs) for joint tissue repair. The use of iPSCs and EVs together in acellular therapies has the potential to provide a safe and effective treatment option for joint tissue repair. The review examines the benefits of these therapies and discusses future research directions, including the use of bioinspired EV-mimicking nanoparticles and the modulation of the immunogenicity of donor iPSCs. The review also addresses the potential ethical implications of these therapies and proposes solutions for addressing these concerns. Overall, this review suggests that iPSCs and EVs-based acellular therapies could revolutionize regenerative medicine for arthritis treatment, providing a promising avenue for future research.

Osteoarthritis acellular therapies joint tissue repair iPSCs treatment ischemic diseases

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

0

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.